The tertiary structure of the integrin heterodimer is currently unknown, al
though several predictive models have been generated. Detailed structural s
tudies of integrins have been consistently hampered for several reasons, in
cluding the small amounts of purified protein available, the large size and
conformational flexibility of integrins, and the presence of transmembrane
domains and N-linked glycosylation sites in both receptor subunits. As a f
irst step toward obtaining crystals of an integrin receptor, we have expres
sed a minimized dimer. By using the Fc dimerization and mammalian cell expr
ession system designed and optimized by Stephens et al. (Stephens, P. E., O
rtlepp, S., Perkins, V. C., Robinson, M. K., and Kirby, H. (2000) Cell. Adh
es. Commun. 7, 377-390), a series of recombinant soluble human alpha (5)bet
a (1) integrin truncations have been expressed as Fc fusion proteins. These
proteins were examined for their ligand-binding properties and for their e
xpression of anti-integrin antibody epitopes. The shortest functional alpha
(5)-subunit truncation contained the N-terminal 613 residues, whereas the
shortest beta (1)-subunit was a fragment containing residues 121-455. Each
of these minimally truncated integrins displayed the antibody binding chara
cteristics of alpha (5)beta (1) purified from human placenta and bound liga
nd with the same apparent affinity as the native receptor.